Navigation Links
First AXL1717 Clinical Data From Ongoing Phase I/II Study in Cancer Patients has Been Published
Date:9/7/2010

The article, including clinical data from a limited group of AXL1717-treated patients, by Drs. Ekman, Bergqvist, Frodin and colleagues, was recently published in Acta Oncologica, Early Online 1-7, 2010. The publication describes four heavily pretreated patients with progressive and advanced squamous non-small cell lung cancer (NSCLC) without any remaining therapeutic options. The patients were treated with AXL1717 for notably long time periods, and in addition to reporting that the drug was well tolerated the authors conclude that during: "more than seven months of AXL1717 treatment as third or fourth line treatment, the reported patients did not develop any additional metastases."

"We are pleased to report the first clinical experience in a peer-reviewed publication. These patients, with squamous NSCLC with tumor progression at baseline, represent a selected subgroup but lack a control group. We are encouraged by the results especially since the data was collected in a phase I setting with the primary objectives to establish the tolerability and pharmacokinetics of AXL1717. Squamous NSCLC is relatively unresponsive to regular cytotoxic chemotherapy but the cells of this cancer have been shown to display a high density of the IGF-1 receptor, the therapeutic target for AXL1717", says Johan Harmenberg, CEO Axelar AB.

TO THE EDITORS

About Axelar

Axelar AB is a Swedish biotech company founded in 2003. The company is developing insulin-like growth factor-1 (IGF-1) receptor inhibitors for treatment of cancer and other diseases. Axelar is part of the Karolinska Development portfolio of companies. http://www.axelar.se

About AXL1717

Axelar's lead compound, AXL1717, provides a novel treatment regimen for a wide range of cancers. AXL1717 is the first targeted oral small-molecule IGF-1 receptor inhibitor with no effect on the insulin receptor. AXL1717 is presently undergoing phase I/II c
'/>"/>

SOURCE Karolinska Development AB and Axelar AB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. China Cord Blood Corporation to Announce First Quarter Fiscal 2011 Financial Results
2. First Aid Supplier HART Health Acquires Competitor and Continues Expansion
3. Abbott Receives FDA Approval for First Automated Molecular Test for Assessing Hepatitis B Treatment
4. Magic-Seal Packaging Products to Introduce First Vytex® Natural Rubber Latex Napkin Rings
5. Medisafe 1 Technologies Finalises Contract to Develop Prototype of the Worlds First Ever Medicinal Syringe-Locking Device
6. Swiss Breast Cancer Patient Becomes First in World to Receive Treatment Using Gated RapidArc from Varian Medical Systems
7. Elbit Imaging Announces Insightec Treats First Prostate Cancer Patients in Clinical Trials
8. Ascension Orthopedics Implants First PyroCarbon Shoulder Device in United Kingdom
9. BMP Sunstones Hao Wawa (Good Baby) Brand Ranked First Among Chinas Top Three Pediatric Medicine Brands
10. Cyberonics Reports Strong Fiscal 2011 First Quarter Results
11. Ambry Genetics Announces the Addition of Illumina HiSeq 2000 and First 510(K) Approved BeadXpress® to Its Sequencing and Genotyping Capabilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... July 22, 2014 Sanofi Pasteur, the vaccines division ... announced today that the first lots of Fluzone ® ... been released by the U.S. Food and Drug Administration (FDA) ... representing the first of at least 65 million doses of ... delivered to U.S. health care providers and pharmacies in August. ...
(Date:7/22/2014)... -- Halozyme Therapeutics, Inc. (NASDAQ: HALO ) today ... patients in its ongoing Phase 2 trial (Study 202) ... revised clinical protocol agreed to with the FDA in ... proprietary recombinant human hyaluronidase under development for the systemic ... "Our diligent effort to rapidly re-initiate patient enrollment and ...
(Date:7/22/2014)... 2014 The Intellectual Property ... the world,s leading provider of intelligent information ... Cortellis Clinical Trials Intelligence , its global ... with the documentation of more than 180,000 ... greater and quicker access to critical data ...
Breaking Medicine Technology:Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 2Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 3Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 4Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 5Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 6Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 7Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 2Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 3Thomson Reuters Cortellis Clinical Trials Intelligence Reaches Industry Milestone with 180,000 Clinical Trials 2Thomson Reuters Cortellis Clinical Trials Intelligence Reaches Industry Milestone with 180,000 Clinical Trials 3
... LONDON, Jan. 19, 2011 Jayex – ... specialist, today announces the launch of Med-Extranet ... offers hospitals, clinics, and GP surgeries online access to ... can be displayed on patient waiting room screens ...
... 2011 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: ... manufacturer of medical dressings, medical disposables and non-woven fabric ... today that the Company will participate in Arab Health ... at the International Convention Exhibition Centre in Dubai, UAE. ...
Cached Medicine Technology:Digital Display System Specialist Jayex Launches Med-Extranet Online Media Library 2Digital Display System Specialist Jayex Launches Med-Extranet Online Media Library 3Winner Medical to Participate in Arab Health 2011, International Healthcare Exhibition, in Dubai 2Winner Medical to Participate in Arab Health 2011, International Healthcare Exhibition, in Dubai 3
(Date:7/22/2014)... Antonio, TX (PRWEB) July 22, 2014 Dr. ... Designed with existing patients and new visitors in mind, one ... clean, modern and visual layout that makes navigation very easy. ... make the experience of going to the dentist affordable, convenient ... , One helpful new feature is an appointment scheduling system ...
(Date:7/22/2014)... Indianapolis, IN (PRWEB) July 22, 2014 ... benefits advisory organization, announces that Les McPhearson, an insurance ... serve as CEO effective immediately and be based in ... Calise, said, "I am delighted that Les chose to ... is perfectly qualified to address the many challenges facing ...
(Date:7/22/2014)... HealthDay Reporter TUESDAY, July 22, 2014 (HealthDay ... in the veins of the legs appear no different in ... risk of bleeding and average hospitalization bills that are three ... finds. The standard treatment for these clots -- known ... compression stockings. The other, more expensive treatment delivers medication directly ...
(Date:7/22/2014)... 22, 2014) The American Society of Hematology (ASH) ... School of Medicine, and Robert P. Hebbel, MD, of ... Ernest Beutler Lecture and Prize for their significant research ... The Ernest Beutler Lecture, named for the late Ernest ... for more than 50 years, is a two-part lectureship ...
(Date:7/22/2014)... research at the University of Utah,s John A. Moran ... of Eye Research (ISER) as the recipient of the ... Award in Retina Research., The award recognizes lifetime achievement ... contribution to the understanding of vitreoretinal diseases or disorders. ... ISER Biennial Meeting in San Francisco, where Marc will ...
Breaking Medicine News(10 mins):Health News:Dr. Dental Reveals Exciting New Website 2Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 2Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 3Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 4Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 5Health News:Study Casts Doubt on Costly Treatment for Leg Clots 2Health News:Study Casts Doubt on Costly Treatment for Leg Clots 3Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 2Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 3Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 4Health News:University of Utah researcher Robert Marc receives Paul Kayser International Award 2
... Del., Jan. 8 DuPont (NYSE: DD ... Protection,Agency for Agility(TM) SG herbicide, a new product ... for broad spectrum weed control, including,ALS resistant species. ... of action in a single formulation to offer,convenient, ...
... spending slowed for first time since its inception in ... new Medicare prescription drug plan was largely responsible for ... which was double the increase in spending from the ... Medicare spending reached $401.3 billion, an increase from $338 ...
... found that Medicare spending across the country varies greatly. But ... the same no matter which region a person lives in. ... is no value to the excess costs in high-spending areas. ... as a model suggests this is not correct. While ...
... promoting innovation and fuelled by the brain gain of ... biotech industry only needs a more favourable investment climate ... of therapies and medicines both new and low-cost ... Long considered a skillful product replicator, China today boasts ...
... announced today,that it has entered into an agreement with ... product. Breckenridge expects to file an,ANDA with the FDA ... AG will,supply and Breckenridge will market and distribute the ... agreement, Breckenridge will submit an ANDA to the,U.S. Food ...
... a colonoscopy can play a life-saving role by encouraging ... cancer screenings, according to new research from the University ... provide important information to combat myths and fears that ... their doctors often fail to address. In a randomized ...
Cached Medicine News:Health News:New DuPont(TM) Agility(TM) SG Herbicide Offers Wheat Growers Answers to Changing Weed Control Needs 2Health News:Medicare Drug Plan Fuels Health-Care Spending 2Health News:Medicare Drug Plan Fuels Health-Care Spending 3Health News:Higher Medicare spending yields mixed bag for patients 2Health News:Higher Medicare spending yields mixed bag for patients 3Health News:China's biotech industry: An Asian dragon is growing 2Health News:China's biotech industry: An Asian dragon is growing 3Health News:China's biotech industry: An Asian dragon is growing 4Health News:China's biotech industry: An Asian dragon is growing 5Health News:China's biotech industry: An Asian dragon is growing 6Health News:China's biotech industry: An Asian dragon is growing 7Health News:Breckenridge Pharmaceutical Signs Long Term Agreement with Helm AG (Hamburg, Germany) 2Health News:Colonoscopy fears overcome when patients support patients 2Health News:Colonoscopy fears overcome when patients support patients 3
Landolt hypophysectomie instrument, spoon, bayonet-shaped, flexible....
Hardy pituitary spoon, bayonet, malleable....
... Sundt AVM Micro ... construction, non-magnetic, MRI compatible, ... coiled, high minimum closing ... of small perforating vessels ...
... Cougar is an Anterior Spinal Implant system. ... approximating that of cortical bone. The result ... requirements of anterior column support, while optimizing ... sharing design. Incorporates an anatomic design with ...
Medicine Products: